Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
X-ACKT_XPF-010-303: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Bensalem Owen, Meriem
(PI)
Neurology
Overview
Grants and Contracts Details
Status
Active
Effective start/end date
8/9/23
→
8/9/25
Funding
Xenon Pharmaceuticals Incorporated:
$16,218.00
View all
View less